Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant. - Wikidata - wikimedia - TriplyDB

Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.

Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.

http://www.wikidata.org/entity/Q37346963

about

The impact of structural biology in medicine illustrated with four case studies.A Switchable Site-Specific Antibody Conjugate.A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3.

P2860

Q38698199-F1FD5A75-A55D-4E78-A280-71931A7C2281 Q50027030-7C091E30-970C-4096-AC7D-F3D66F6FE107 Q52679662-9CAD09AF-F545-493A-8C32-6AA9A9EE7DE9

P2860

Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.

http://www.wikidata.org/entity/Q37346963

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.

@en

Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.

@nl

type

label

Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.

@en

Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.

@nl

prefLabel

Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.

@en

Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.

@nl

P1433

Q37346963-418D3D0B-7252-402D-B376-40616964E88E

P1476

Q37346963-0CBAD5D1-33CC-4661-8605-A1B8C277B817

P2093

Q37346963-05019D45-9B68-4044-A5E9-9D3920A461BF

Q37346963-1E64E0F1-877B-48EF-B959-5F696994FF57

Q37346963-2137E002-593A-4176-89F4-E78BC621D9BC

Q37346963-32CF7D18-8956-4034-8D0A-BFA3BD02EEF7

Q37346963-3D3FFB3C-466A-412D-A82B-849787DE0FC0

Q37346963-4D4F0E8C-913F-4391-93B9-BC7887D64410

Q37346963-5734098C-5E1B-4001-AC5E-B200DDCAC382

Q37346963-84814F16-DBF1-40DB-B356-8F57A4F4A55B

Q37346963-8676D1E6-417B-4E0C-9F13-41061C685BE6

Q37346963-906B37CC-F5DA-48AA-8947-6F783F37007B

P2860

Q37346963-02675E7E-A5E2-4772-8E71-20E1A8280A8F

Q37346963-0B80FB1E-28A7-4DB6-B50F-57FBB4510CEF

Q37346963-10989E81-A3BF-4A8B-B970-253305D63F5E

Q37346963-26102263-CF55-4322-91BB-4A7B4E084422

Q37346963-36377CC0-533B-4E35-BCD8-92D7C9DC0D64

Q37346963-38E17D87-0841-4798-9749-8AA39CCF4308

Q37346963-3928594B-85AA-4553-AD94-FA731C85204F

Q37346963-424E40BE-8B78-499C-8EAA-C0C25B664DB6

Q37346963-49A92240-C441-4D3E-90FE-CDAE42E5D30C

Q37346963-4DCCA14F-CE26-4641-B096-4759FD4418D2

P304

Q37346963-4C562F89-E24D-498A-865C-A7B7DEB64ACF

P31

Q37346963-9DE09E88-D7AD-4C88-B652-5894F31F88F0

P356

Q37346963-2DEFFAE7-6D4A-43EA-AD04-E9BF5922846D

P407

Q37346963-AC46E44D-1FC8-49C1-9478-73CE916DDBB8

P433

Q37346963-B97687EB-FF09-4476-AB61-B7E6092CAD0F

P478

Q37346963-3AF8D7C6-1ED1-4365-84E3-DE160B15CDA3

P50

Q37346963-79E4FAB3-0CBD-412C-91D2-2C466EB4CDFE

Q37346963-85C10579-F045-4FC4-B9D6-E5611985A58D

Q37346963-D11A1A0A-0F1D-487A-B904-BB2252606974

P577

Q37346963-450E94BD-C0EB-4E46-B8DF-36C828621D51

P698

Q37346963-28A4A829-DB79-42C2-864D-1CD9098C8BD9

P921

Q37346963-A95C4162-B557-4DF1-8106-A196D4940A66

P932

Q37346963-187486CB-A155-4E65-89E6-97B101C02994

P356

PNAS.1612803113

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.

@en

P2093

Argyrios N Theofilopoulos

http://www.w3.org/2001/XMLSchema#string

Arnab K Chatterjee

http://www.w3.org/2001/XMLSchema#string

Chase Gabrelow

http://www.w3.org/2001/XMLSchema#string

Danling Wang

http://www.w3.org/2001/XMLSchema#string

John Teijaro

http://www.w3.org/2001/XMLSchema#string

Peter G Schultz

http://www.w3.org/2001/XMLSchema#string

Qiangwei Fu

http://www.w3.org/2001/XMLSchema#string

Rongsheng E Wang

http://www.w3.org/2001/XMLSchema#string

Timothy M Wright

http://www.w3.org/2001/XMLSchema#string

Victor Chi

http://www.w3.org/2001/XMLSchema#string

P2860

K+ channels as targets for specific immunomodulation

CD4+CD28- costimulation-independent T cells in multiple sclerosis

The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases

Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis

A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library

Reshaping Antibody Diversity

Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes

ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide

Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection

P304

11501-11506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1612803113

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Kristen Johnson

P577

2016-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27663736

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

P932

5068325

http://www.w3.org/2001/XMLSchema#string